Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Ads

You May Also Like

Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018

BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing ...

CytomX to Present at the Jefferies 2017 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

FIT Biotech Oy: FIT Biotech’s long time CEO retires

FIT Biotech Oy Company Release December 31, 2015 at 13:00 hrs EET   FIT Biotech's long ...